Mucopolysaccharidosis (MPS) Center

Newborn Screening

In 2016, mucopolysaccharidosis type I was added to the Recommended Uniform Screening Panel, which is the list of disorders that are screened at birth and recommended by the Secretary of the Department of Health and Human Services in the United States.

If your baby has received a positive newborn screening test or a biochemical diagnosis of Hurler syndrome, we're here to help no matter where you are located. Please email the Mucopolysaccharidosis (MPS) Center (landb018@umn.edu).

Our multidisciplinary team of healthcare professionals at the University of Minnesota Masonic Children’s Hospital collaborates with the Minnesota Department of Health Newborn Screening Program (MDH-NBS) to address the varied and long-term spectrum of clinical needs for patients with Hurler syndrome.

The healthcare team includes international MPS experts in pediatric blood and marrow transplantation for MPS, cardiology, genetics, neurology, neuropsycholoigy, orthopaedics, and a public healthcare coordinator/newborn screening follow-up specialist from the Minnesota Department of Health.

We offer comprehensive diagnostic evaluations, consultations, and coordinated follow-up care based upon the initial clinical encounter. Ongoing follow-up and monitoring is facilitated.

Clinical research participation opportunities are available to eligible subjects for innovative monitoring and treatment modalities.

Ryland
Cooper